Lv41
760 积分 2024-10-16 加入
Safety and efficacy of tumor-infiltrating lymphocyte (TIL) therapy with reduced-dose lymphodepleting conditioning in high-risk metastatic melanoma patients
1小时前
已完结
Axes of biological variation in diffuse large B cell lymphoma
4天前
已完结
Anti–CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE
8天前
已完结
Immune cells in circulation serve as living biomarkers for inflammatory diseases
11天前
已完结
Strategies to reduce the risks of mRNA drug and vaccine toxicity
28天前
已完结
IL-9 signaling redirects CAR T cell fate toward CD8+ memory and CD4+ cycling states, enhancing antitumor efficacy
1个月前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
1个月前
已完结
IL-36γ armored CAR T cells reprogram neutrophils to induce endogenous antitumor immunity
1个月前
已完结
Liquid biopsies across the cancer care continuum
1个月前
已完结
Bioengineering and nephrology converge to drive kidney-targeted therapies
1个月前
已完结
皖公网安备34019202002308
